← Back
$APRE All transactions

Aprea Therapeutics, Inc.

A

$ Value

$0

Shares

40,380

Price

$0

Filed

Mar 16

Insider

Name

Hamill John P.

Title

SrVP/CFO/Prin Fin & Acct Ofcr

CIK

0001716213

Roles

Officer

Transaction Details

Transaction Date

2026-03-12

Code

A

Table

Derivative

Ownership

Direct

Equity Swap

No

Shares After

40,380

Footnotes

These shares represent restricted stock units and shall vest and be settled in the Issuer's common stock in three (3) equal annual installments beginning on March 12, 2027, until vested in full, subject to the reporting person's continued employment through and including the applicable vesting dates and subject to acceleration under certain conditions. | Twenty-five percent of these options vest on March 12, 2027, with the remaining options vesting ratably over the following 36 months, subject to the reporting person's continued employment through and including the applicable vesting dates and subject to acceleration under certain conditions.

Filing Info

Accession No.

0001104659-26-028653

Form Type

4

Issuer CIK

0001781983

Hamill John P.'s History

Date Ticker Type Value
2026-03-31 APRE $25K
2026-03-31 APRE
2026-03-12 APRE A $0
2026-03-12 APRE A $0
2026-01-30 APRE $5K
2026-01-30 APRE
2025-12-10 APRE $6K
2025-12-10 APRE

Other Insiders at APRE (90d)

Insider Bought Sold Last
Peters Richard $100K 2026-03-31
Hamill John P.
SrVP/CFO/Prin Fin & Acct Ofcr
$30K 2026-03-31
Gilad Oren
President/CEO
$25K 2026-03-12